The Response to Intralesional IL-2 and/or BCG Treatment for Cutaneous Metastatic Melanoma

首次发布于 2019 年 4 月 26 日

Intratumoral Targeted Hyperthermia Therapy (THT) for Cutaneous Metastatic Melanoma

计划入组 10 人 · 首次发布于 2025 年 3 月 11 日

Intratumoral Targeted Hyperthermia Therapy (THT) for Stage 3C/3D/4M1 Cutaneous Metastatic Melanoma

计划入组 10 人 · 首次发布于 2025 年 3 月 25 日

Metastatic melanoma(Asylia Diagnostics)

GPR19 antagonists (metastatic melanoma/lung cancer)

Q-204

MELANOMA INSTITUTE AUSTRALIA

Australia

Cutis Academy of Cutaneous Sciences

India

MELANOMA AND SKIN CANCER TRIALS LIMITED

Australia

Sona Nanotech's Targeted Hyperthermia Therapy Shows 80% Response Rate in First-in-Human Melanoma Study

Study Finds Strong Link Between Cutaneous Melanoma and Uveal Melanoma Risk

Genmab Advances Two Phase 3 and Phase 2 Trials Testing Acasunlimab Combinations in Lung Cancer and Melanoma